These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 38548305)

  • 1. Neurofilament Light Chain Levels Interact with Neurodegenerative Patterns and Motor Neuron Dysfunction in Amyotrophic Lateral Sclerosis.
    Tilsley P; Moutiez A; Brodovitch A; Mendili MME; Testud B; Zaaraoui W; Verschueren A; Attarian S; Guye M; Boucraut J; Grapperon AM; Stellmann JP
    AJNR Am J Neuroradiol; 2024 Apr; 45(4):494-503. PubMed ID: 38548305
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cortical Thinning Pattern of Bulbar- and Spinal-onset Amyotrophic Lateral Sclerosis: a Surface-based Morphometry Study.
    Chen ZY; Liu MQ; Ma L
    Chin Med Sci J; 2018 Jun; 33(2):100-106. PubMed ID: 29976279
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Region-specific atrophy of precentral gyrus in patients with amyotrophic lateral sclerosis.
    Qin Y; Zhang S; Jiang R; Gao F; Tang X; Zhu W
    J Magn Reson Imaging; 2018 Jan; 47(1):115-122. PubMed ID: 28591490
    [TBL] [Abstract][Full Text] [Related]  

  • 4. High-Resolution 7T MR Imaging of the Motor Cortex in Amyotrophic Lateral Sclerosis.
    Cosottini M; Donatelli G; Costagli M; Caldarazzo Ienco E; Frosini D; Pesaresi I; Biagi L; Siciliano G; Tosetti M
    AJNR Am J Neuroradiol; 2016 Mar; 37(3):455-61. PubMed ID: 26680464
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Amyotrophic lateral sclerosis with upper motor neuron predominance: diagnostic accuracy of qualitative and quantitative susceptibility metrics in the precentral gyrus.
    Lo Russo F; Contarino VE; Conte G; Morelli C; Trogu F; Casale S; Sbaraini S; Caschera L; Genovese V; Liu C; Cinnante CM; Silani V; Triulzi FM
    Eur Radiol; 2023 Nov; 33(11):7677-7685. PubMed ID: 37606662
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cortical thinning and clinical heterogeneity in amyotrophic lateral sclerosis.
    Mezzapesa DM; D'Errico E; Tortelli R; Distaso E; Cortese R; Tursi M; Federico F; Zoccolella S; Logroscino G; Dicuonzo F; Simone IL
    PLoS One; 2013; 8(11):e80748. PubMed ID: 24278317
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Serum neurofilament light chain levels as a marker of upper motor neuron degeneration in patients with Amyotrophic Lateral Sclerosis.
    Gille B; De Schaepdryver M; Goossens J; Dedeene L; De Vocht J; Oldoni E; Goris A; Van Den Bosch L; Depreitere B; Claeys KG; Tournoy J; Van Damme P; Poesen K
    Neuropathol Appl Neurobiol; 2019 Apr; 45(3):291-304. PubMed ID: 29908069
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Toward a marker of upper motor neuron impairment in amyotrophic lateral sclerosis: A fully automatic investigation of the magnetic susceptibility in the precentral cortex.
    Contarino VE; Conte G; Morelli C; Trogu F; Scola E; Calloni SF; Sanmiguel Serpa LC; Liu C; Silani V; Triulzi F
    Eur J Radiol; 2020 Mar; 124():108815. PubMed ID: 31945675
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical Profiles and Patterns of Neurodegeneration in Amyotrophic Lateral Sclerosis: A Cluster-Based Approach Based on MR Imaging Metrics.
    Milella G; Introna A; Mezzapesa DM; D'Errico E; Fraddosio A; Ucci M; Zoccolella S; Simone IL
    AJNR Am J Neuroradiol; 2023 Apr; 44(4):403-409. PubMed ID: 36958798
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hyperintensity of the corticospinal tract on FLAIR: A simple and sensitive objective upper motor neuron degeneration marker in clinically verified amyotrophic lateral sclerosis.
    Jin J; Hu F; Zhang Q; Jia R; Dang J
    J Neurol Sci; 2016 Aug; 367():177-83. PubMed ID: 27423585
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Significance of CSF NfL and tau in ALS.
    Schreiber S; Spotorno N; Schreiber F; Acosta-Cabronero J; Kaufmann J; Machts J; Debska-Vielhaber G; Garz C; Bittner D; Hensiek N; Dengler R; Petri S; Nestor PJ; Vielhaber S
    J Neurol; 2018 Nov; 265(11):2633-2645. PubMed ID: 30187162
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cross-sectional and longitudinal assessment of the upper cervical spinal cord in motor neuron disease.
    van der Burgh HK; Westeneng HJ; Meier JM; van Es MA; Veldink JH; Hendrikse J; van den Heuvel MP; van den Berg LH
    Neuroimage Clin; 2019; 24():101984. PubMed ID: 31499409
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Structural imaging differences and longitudinal changes in primary lateral sclerosis and amyotrophic lateral sclerosis.
    Kwan JY; Meoded A; Danielian LE; Wu T; Floeter MK
    Neuroimage Clin; 2012; 2():151-60. PubMed ID: 24179768
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Iron accumulation in deep cortical layers accounts for MRI signal abnormalities in ALS: correlating 7 tesla MRI and pathology.
    Kwan JY; Jeong SY; Van Gelderen P; Deng HX; Quezado MM; Danielian LE; Butman JA; Chen L; Bayat E; Russell J; Siddique T; Duyn JH; Rouault TA; Floeter MK
    PLoS One; 2012; 7(4):e35241. PubMed ID: 22529995
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Structural and functional underpinnings of precentral abnormalities in amyotrophic lateral sclerosis.
    Cheng L; Yuan Y; Tang X; Zhou Y; Luo C; Liu D; Zhang Y; Zhang J
    Eur J Neurol; 2021 May; 28(5):1528-1536. PubMed ID: 33404153
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Semiautomated Evaluation of the Primary Motor Cortex in Patients with Amyotrophic Lateral Sclerosis at 3T.
    Donatelli G; Retico A; Caldarazzo Ienco E; Cecchi P; Costagli M; Frosini D; Biagi L; Tosetti M; Siciliano G; Cosottini M
    AJNR Am J Neuroradiol; 2018 Jan; 39(1):63-69. PubMed ID: 29122765
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Longitudinal imaging in
    Floeter MK; Bageac D; Danielian LE; Braun LE; Traynor BJ; Kwan JY
    Neuroimage Clin; 2016; 12():1035-1043. PubMed ID: 27995069
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dominant Heterogeneity of Upper and Lower Motor Neuron Degeneration to Motor Manifestation of Involved Region in Amyotrophic Lateral Sclerosis.
    Jin J; Hu F; Zhang Q; Chen Q; Li H; Qin X; Jia R; Kang L; Dang Y; Dang J
    Sci Rep; 2019 Dec; 9(1):20059. PubMed ID: 31882886
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Diagnostic and Prognostic Biomarkers in Amyotrophic Lateral Sclerosis: Neurofilament Light Chain Levels in Definite Subtypes of Disease.
    Gaiani A; Martinelli I; Bello L; Querin G; Puthenparampil M; Ruggero S; Toffanin E; Cagnin A; Briani C; Pegoraro E; Sorarù G
    JAMA Neurol; 2017 May; 74(5):525-532. PubMed ID: 28264096
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Brain signal intensity changes as biomarkers in amyotrophic lateral sclerosis.
    Vázquez-Costa JF; Mazón M; Carreres-Polo J; Hervás D; Pérez-Tur J; Martí-Bonmatí L; Sevilla T
    Acta Neurol Scand; 2018 Feb; 137(2):262-271. PubMed ID: 29082510
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.